In Regard to Albuquerque et al
We applaud the University of Texas Southwestern Department of Radiation Oncology for conducting “A phase II trial of stereotactic ablative radiotherapy as a boost for locally advanced cervical cancer,” a necessary prospective study on definitive dose delivery for patients unable to undergo brachytherapy.1 The involved trialists were undoubtedly deliberate and meticulous in its design and e xecution, akin to their groundbreaking work with lung stereotactic body radiation therapy (SBRT). Although these results unfortunately showed high rates of rectal toxicity, the data does not indicate a failure of SBRT, but rather an opportunity for further investigation.
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Shraddha M. Dalwadi, Mark D. Bonnen, Michelle S. Ludwig Tags: Comment Source Type: research
More News: Biology | Brachytherapy | Cancer | Cancer & Oncology | Cervical Cancer | Physics | Radiation Therapy | Radiology | Study | Texas University | Toxicology